首页> 外文OA文献 >JAAD Game Changers: Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)

【2h】

JAAD Game Changers: Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)

机译：JAAD游戏换句：杜帕里姆治疗在患者报告的结果（专业人士）中提供临床有意义的改善：成年患者中度至严重特征性皮炎（广告）的成年患者中的IIB，随机，安慰剂对照，临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Eden Lake;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. JAAD Game Changers: Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD) [J] . Lake Eden Journal of the American Academy of Dermatology . 2019,第4期

机译：JAAD游戏变化器：杜帕里姆治疗在患者报告的结果（专业人士）中提供临床有意义的改善：成年患者中度至严重特应性皮炎（广告）的成人患者中的IIB，随机，安慰剂控制，临床试验
2. Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD) [J] . Simpson Eric L., Gadkari Abhijit, Worm Margitta, Journal of the American Academy of Dermatology . 2016,第3期

机译：Dupilumab治疗可为患者报告的结局（PRO）提供临床上有意义的改善：一项针对中度至重度特应性皮炎（AD）成年患者的IIb期，随机，安慰剂对照的临床试验
3. Dupilumab treatment improves quality of life in adult patients with moderate‐to‐severe atopic dermatitis: results from a randomized, placebo‐controlled clinical trial [J] . Tsianakas A., Luger T.A., Radin A. British Journal of Dermatology . 2018,第2期

机译：杜帕米布治疗改善了成年患者中度至严重的特征性皮炎的生活质量：随机安慰剂对照临床试验的结果
4. Clinical Improvement and Immunological Changes of Atopic Dermatitis in Patients Undergoing Subcutaneous Immunotherapy with Depigmented Polymerized House Dust Mite Allergens [C] . C. Bussmann, AJ. Hart, S. Vrtala, Collegium Internationale Allergologicum . 2007

机译：用沉淀聚合房屋粉尘螨过敏原患者检查患者特应性皮炎的临床改善和免疫变化
5. A comprehensive assessment of mucositis due to radiation for head and neck cancer: Pathophysiology, clinical and patient-reported outcomes, and a proposal for a novel treatment based on ayurvedic medicine. [D] . Ramnath, Rajesh. 2016

机译：头颈部癌放疗引起的粘膜炎的综合评估：病理生理，临床和患者报告的结局，以及基于阿育吠陀医学的新型治疗方案的建议。
6. Dupilumab Improves General Health-Related Quality-of-Life in Patients with Moderate-to-Severe Atopic Dermatitis: Pooled Results from Two Randomized Controlled Phase 3 Clinical Trials [O] . Eric L. Simpson 2017

机译：Dupilumab改善中度至重度特应性皮炎患者的一般健康相关生活质量：两项随机对照三期临床试验的汇总结果
7. Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial [O] . A. Tsianakas, T.A. Luger, A. Radin 2018

机译：Dupilumab治疗改善了成年患者的生活质量，中度至严重的特征性皮炎：来自随机，安慰剂对照的临床试验的结果

JAAD Game Changers: Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)

著录项

引文网络

相似文献

相关主题

期刊订阅